NCT04131361

Brief Summary

Background: Intravenous fluid replacement during transurethral resection of the prostate is still unclear. Ultrasonography of the inferior vena cava (IVC) has been recently used to assess the volume status and predict fluid responsiveness. In this double-blind, randomized controlled study, we will assess the IVC at baseline and at subsequent time points after spinal anesthesia, and according to IVC diameter will give the replacement challenge colloid. Potential problems during TURP are mostly due to either fluid overload or bleeding: Intraoperative TURP syndrome, Hemorrhage, Myocardial ischemia, Hypothermia, Prostatic capsular perforation, Bladder or urethral perforation. Postoperative TURP syndrome, myocardial ischemia/infarction, Postoperative cognitive impairment. Study Hypothesis: Strict colloid volume optimization using US-guided IVC diameter calculation aiming decrease the total IV fluid volume and accommodate the transurethral inevitable absorption of currently used irrigation crystalloid fluid (Nacl0.9%) that accidentally absorbed and change it from a circulatory overload to a complementary part of the replacement IV fluids preventing fluid overload and TURP syndrome. Aim of the work: To reduce Intraoperative and postoperative fluid overload during TURP surgery with hemodynamic stability relaying up on US-guided IVC diameter dependent Strict IV Colloid replacement volume optimization. Methods: A prospective randomized controlled trial on ASAI-III male patient aged 40-80 years old subjected to transurethral endoscopic resection of the prostate (TURP) surgery. Then patients will be divided into 2 groups according to the IV infusion fluid type as follow: Crystalloid -control group: (preload plus continuous IO Ringer acetate crystalloid 4/2/1 rule infusion) according to the usual 4/2/1 rule. Not guided by IVC diameter but IVC diameter will be calculated using the US and recorded at baseline just after spinal anesthesia and then every 30 minutes till the end of surgery. Loop Diuretic (Furosemide) will be given according to the maximum diameter of the IVC as follow; 10mg if IVC\>2.5Cm. Colloid- study group: (preload plus colloid challenge only); Fluid challenge boluses of 250 mL (over 5 minutes using a pressurizer) 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride (voluven®) if the IVC\<1.7(higher limit of normal) will be given guided by IVC diameter at baseline just after spinal anesthesia and then every 30 minutes till the end of surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 12, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 18, 2019

Completed
3 years until next milestone

Study Start

First participant enrolled

October 1, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 25, 2022

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
Last Updated

June 12, 2023

Status Verified

June 1, 2023

Enrollment Period

3 months

First QC Date

October 12, 2019

Last Update Submit

June 8, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • total iv fluids

    just after end of surgery

Secondary Outcomes (6)

  • serum Na at end of surgery

    just after end of surgery

  • serum K at end of surgery

    just after end of surgery

  • ximum and minimum IVC diameter

    serial during surgery

  • IVC-CI

    serial during surgery

  • Incidence of bradycardia

    serial during surgery

  • +1 more secondary outcomes

Study Arms (2)

Crystalloid -control group:

ACTIVE COMPARATOR
Other: Ultrasound-guided Inferior vena cava diameter dependent colloid challenge versus routine crystalloid strategy Fluid replacement

Colloid- study group:

EXPERIMENTAL
Other: Ultrasound-guided Inferior vena cava diameter dependent colloid challenge versus routine crystalloid strategy Fluid replacement

Interventions

The inferior vena cava largest and smallest diameters will be measured proximal to the opening of the hepatic veins in the longitudinal axis with the M-mode using a 8-2 MHz curved array ultrasound probe placed longitudinally in the subcostal region.

Colloid- study group:Crystalloid -control group:

Eligibility Criteria

Age40 Years - 80 Years
Sexmale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients subjected to transurethral resection of prostate TURP.
  • ASA I\&II
  • Age 40-80years old. prostate size 45-100
  • Surgical procedure: laser and Bipolar TURP using saline 0,9% irrigation.

You may not qualify if:

  • Height \<150 cm.
  • Weight \<60 kg.
  • Body mass index ≥45 kg/m2.
  • Contraindications to spinal anesthesia (increased intracranial pressure or local skin infection).
  • Uncontrolled; Diabetes mellitus, cardiovascular failure, cerebrovascular uncontrolled deficite, or other renal disease.
  • Hemoglobin \<10 gm/dL.
  • International Normalized Ratio \>1.4
  • Platelet count \<100,000 /mm3.
  • Preoperative serum creatinine \>1.5 mg/dL

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Anesthesia Department

Al Mansurah, Dakahlia Governorate, 35931, Egypt

Location

MeSH Terms

Conditions

Edema

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor os anesthesia ICU & Pain medicine.

Study Record Dates

First Submitted

October 12, 2019

First Posted

October 18, 2019

Study Start

October 1, 2022

Primary Completion

December 25, 2022

Study Completion

December 30, 2022

Last Updated

June 12, 2023

Record last verified: 2023-06

Locations